Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Inulin + sodium selenite (SS) is a combination of the prebiotic fiber inulin and the mineral supplement sodium selenite. This combination is primarily investigated for its synergistic effects on gut health, immune modulation, and the prevention of colorectal cancer. Inulin, a polysaccharide belonging to the fructan class, acts as a prebiotic by selectively stimulating the growth of beneficial gut bacteria such as *Bifidobacterium*. Sodium selenite serves as a source of selenium, an essential trace element that is a component of selenoproteins with antioxidant and anti-inflammatory properties. Research suggests that inulin can enhance the bioavailability of selenium and that the two substances together may more effectively inhibit the development of aberrant crypt foci (ACF) in the colon and modulate the gut microbiota compared to either agent alone. Clinical studies have explored this combination for its impact on gut microbiota composition and immune function in healthy adults and patients at risk for colorectal malignancies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on inulin + sodium selenite.